Interestingly, the molecular modeling studies with hydroxymethyltransferase 2 (SHMT2), a protein that is upregulated in lung and other cancers, revealed that the active hybrids 4b and 4c displayed comparable-to-superior binding affinity than ligand 8Z1, a pyrazolopyran inhibitor. Here, SHMT2 is linked to cancer.